Aoxing Pharmaceutical Company (NYSE:AXN) to Announce Important Company Updates at New York Stock Exchange

Share Article

Aoxing Pharmaceutical Company (NYSE:AXN) Founder & Executive Chairman Zhenjiang Yue ,CFO Wilfred Chow and U.S. managing director Wei Zhang will announce very important company updates to invited media and investors on a press conference held at the NYSE.

News Image
Next big thing is happening here

Past News Releases


Aoxing Pharmaceutical Company, Inc. (NYSE MKT:AXN) ("Aoxing Pharma" or the "Company"), a specialty pharmaceutical company focusing on research, development, manufacturing, and distribution of narcotic, pain-management, and addiction treatment pharmaceuticals will be holding a press conference at New York Stock Exchange on Jun 9th from 3pm to 5pm.

At the conference, this pharmaceutical company will release very important company updates, introducing a project that they have been working on for the past 10 years. The management team will provide more details and give further explanations about this project on that day.

About Aoxing Pharmaceutical Company, Inc.

Aoxing Pharmaceutical Company, Inc. is a US incorporated specialty pharmaceutical company with its operations in China, specializing in research, development, manufacturing and distribution of a variety of narcotics and pain-management products. Headquartered in Shijiazhuang City, outside Beijing, Aoxing Pharma has the largest and most advanced manufacturing facility in China for highly regulated narcotic medicines. Its facility is one of the few GMP facilities licensed for the manufacture of narcotic medicines by the SFDA. For more information, please visit:

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Annabelle zhang
Aoxing Pharmaceutical Company
+1 (917) 376-3588
Email >
Visit website